UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

British journal of pharmacology, 2022-07, Vol.179 (14), p.3496-3511

2022

Link zum Volltext

Verfügbarkeit prüfen

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development

Frontiers in cellular neuroscience, 2019-03, Vol.13, p.124-124

2019

Link zum Volltext

Verfügbarkeit prüfen

A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy

Medicinal research reviews, 2018-07, Vol.38 (4), p.1031-1072

2018

Link zum Volltext

Verfügbarkeit prüfen

A2B Adenosine Receptor and Cancer

International journal of molecular sciences, 2019-10, Vol.20 (20), p.5139

2019

Link zum Volltext

Verfügbarkeit prüfen

Structure of an Agonist-Bound Human A2A Adenosine Receptor

Science (American Association for the Advancement of Science), 2011-04, Vol.332 (6027), p.322-327

2011

Link zum Volltext

Verfügbarkeit prüfen

Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling

Structure (London), 2018-02, Vol.26 (2), p.259-269.e5

2018

Link zum Volltext

Verfügbarkeit prüfen

Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor

Cell, 2018-01, Vol.172 (1-2), p.68-80.e12

2018

Link zum Volltext

Verfügbarkeit prüfen

Two disparate ligand-binding sites in the human P2Y1 receptor

Nature (London), 2015-03, Vol.520 (7547), p.317-321

2015

Link zum Volltext

Verfügbarkeit prüfen

Fragment-based design of selective GPCR ligands guided by free energy simulations

Chemical communications (Cambridge, England), 2021-11, Vol.57 (92), p.1235-1238

2021

Link zum Volltext

Verfügbarkeit prüfen

Adenosine receptors as therapeutic targets

Nature reviews. Drug discovery, 2006-03, Vol.5 (3), p.247-264

2006

Link zum Volltext

Verfügbarkeit prüfen

On the G protein-coupling selectivity of the native A2B adenosine receptor

Biochemical pharmacology, 2018-05, Vol.151 (C), p.201-213

2018

Link zum Volltext

Verfügbarkeit prüfen

Purinergic Signaling in Mast Cell Degranulation and Asthma

Frontiers in pharmacology, 2017-12, Vol.8, p.947-947

2017

Link zum Volltext

Verfügbarkeit prüfen

Agonist-bound structure of the human P2Y12 receptor

Nature (London), 2014-05, Vol.509 (7498), p.119-122

2014

Link zum Volltext

Verfügbarkeit prüfen

Species dependence of A3 adenosine receptor pharmacology and function

Purinergic signalling, 2023-09, Vol.19 (3), p.523-550

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models

Arthritis research & therapy, 2022-12, Vol.24 (1), p.265-13

2022

Link zum Volltext

Verfügbarkeit prüfen

Nucleotides Acting at P2Y Receptors: Connecting Structure and Function

Molecular pharmacology, 2015-08, Vol.88 (2), p.220-230

2015

Link zum Volltext

Verfügbarkeit prüfen

Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors

Scientific reports, 2018-05, Vol.8 (1), p.1-9, Article 8084

2018

Link zum Volltext

Verfügbarkeit prüfen

Anionic phospholipids control mechanisms of GPCR-G protein recognition

Nature communications, 2023-02, Vol.14 (1), p.794-794, Article 794

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists

Purinergic signalling, 2021-12, Vol.17 (4), p.737-746

2021

Link zum Volltext

Verfügbarkeit prüfen

Probing biased/partial agonism at the G protein-coupled A2B adenosine receptor

Biochemical pharmacology, 2014-08, Vol.90 (3), p.297-306

2014

Link zum Volltext

Verfügbarkeit prüfen

Progress in the pursuit of therapeutic adenosine receptor antagonists

Medicinal research reviews, 2006-03, Vol.26 (2), p.131-159

2006

Link zum Volltext

Verfügbarkeit prüfen

Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes

Purinergic signalling, 2023-09, Vol.19 (3), p.565-578

2023

Link zum Volltext

Verfügbarkeit prüfen

Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A1 Adenosine Receptor Antagonists

PloS one, 2012-11, Vol.7 (11), p.e49910

2012

Link zum Volltext

Verfügbarkeit prüfen

A2B adenosine receptor blockade inhibits growth of prostate cancer cells

Purinergic signalling, 2013-06, Vol.9 (2), p.271-280

2013

Link zum Volltext

Verfügbarkeit prüfen

G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions

Purinergic signalling, 2012-09, Vol.8 (3), p.419-436

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 603

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(573)
Mit Volltextzugriff
(569)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Humans
(171)
Animals
(116)
Life Sciences & Biomedicine
(108)
Structure-Activity Relationship
(74)
Biological And Medical Sciences
(61)
Ligands
(59)
Pharmacology & Pharmacy
(59)
Medical Sciences
(57)
Cricetinae
(56)
Pharmacology. Drug Treatments
(55)
Physical Sciences
(53)
Cho Cells
(51)
Models, Molecular
(50)
G Protein-Coupled Receptor
(47)
Adenosine - Analogs & Derivatives
(46)
Neuropharmacology
(41)
Neurotransmitters. Neurotransmission. Receptors
(41)
Peptidergic System . Adenosinergic And Purinergic Systems
(41)
Receptor, Adenosine A3 - Metabolism
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development

A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy

A2B Adenosine Receptor and Cancer

Structure of an Agonist-Bound Human A2A Adenosine Receptor

Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling

Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor

Two disparate ligand-binding sites in the human P2Y1 receptor

Fragment-based design of selective GPCR ligands guided by free energy simulations

Adenosine receptors as therapeutic targets

On the G protein-coupling selectivity of the native A2B adenosine receptor

Purinergic Signaling in Mast Cell Degranulation and Asthma

Agonist-bound structure of the human P2Y12 receptor

Species dependence of A3 adenosine receptor pharmacology and function

Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models

Nucleotides Acting at P2Y Receptors: Connecting Structure and Function

Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors

Anionic phospholipids control mechanisms of GPCR-G protein recognition

Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists

Probing biased/partial agonism at the G protein-coupled A2B adenosine receptor

Progress in the pursuit of therapeutic adenosine receptor antagonists

Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes

Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A1 Adenosine Receptor Antagonists

A2B adenosine receptor blockade inhibits growth of prostate cancer cells

G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions

Suchergebnisse filtern